View Document Preview and Link Document Date: 2010-12-15 01:31:57 Open Document File Size: 192,00 KB Share Result on Facebook
City Plovdiv / / Company Beckman-Coulter Inc / / Country United States / Bulgaria / / / Facility Clinic of Neurosurgery / Trakia University / Medical University / / MedicalCondition how glial tumor / glioblastoma cancer / intracranial tumor / highly aggressive primary tumors / tumor / immune dysfunction / Cancer / tumors / glioma cells / massive necrosis / glioblastoma multiforme / FasL+ tumor / glioma / astrocytoma grade II / primary malignant brain tumors / primary brain tumors / anaplastic astrocytoma grade III / gliomas / malignant glioma / human glioblastoma cells / glioma / immune response / malignant brain tumors / glial brain tumors / Malignant gliomas / highly malignant tumors / especially glioblastoma multiforme / astrocytic tumors / Brain Tumor / glioblastoma / / MedicalTreatment immunosuppression / Neurosurgery / chemotherapy / radiotherapy / surgery / radiation / / Organization Department of General and Clinical Pathology / Department of Neurosurgery / Department of Molecular Biology / Medical Genetics and Immunology / Ethics Committee of Medical UniveristyPlovdiv / Department of Biology / DMedSci Department of Medical Biology / Trakia University / Medical University / / Person H. Jelyazkov / Victoria Sarafian / / / Position Gustafson MP / / Product dexamethasone / / ProvinceOrState Arkansas / / PublishedMedium Molecular Biology / / Technology radiation / antibodies / chemotherapy / Neurosurgery / apoptosis / / SocialTag 
DOI: jimab.1632010_17-19 Journal of IMAB - Annual Proceeding (Scientific Papers) vol. 16, book 3, 2010 IMMUNE RESPONSE IN MALIGNANT GLIOMA I. Koev1, E. Slavov2, D. Staykov1, K. Halacheva2, V. Sarafian1 1) Clinic